A 73-year-old man with interstitial lung disease due to dronedarone

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 2, 2012, Pages 201-202

  Hernández Voth, Ana R ^a   Catalán, Javier Sayas ^a   Benavides Mañas, Pedro D ^a   Ávila Martínez, Régulo J ^a   Peñalver Paolini, Carlos L ^a   Díaz De Atauri Rodríguez, María J ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ATENOLOL; DRONEDARONE;

ABLATION THERAPY; AGED; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DRUG WITHDRAWAL; DYSPEPSIA; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTHYROIDISM; INTERSTITIAL LUNG DISEASE; LETTER; LUNG FUNCTION TEST; MALE; PAROXYSMAL HEART ATRIUM FIBRILLATION; PHYSICAL EXAMINATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SLEEP APNEA SYNDROME; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; TREATMENT OUTCOME;

EID: 84863953772     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/ajrccm.186.2.201     Document Type: Letter

References (4)

1. Naccarelli G, Wolbrette D, Levin V, Samii S, Banchs J, Penny-Peterson E, Gonzalez M. Safety and efficacy of dronedarone in the treatment of atrial fibrillation/flutter. Clin Med Insights Cardiol 2011;5:103-119.
2. Seki S, Itagaki S, Kobayashi M, Hirano T, Iseki K. Amiodarone increases the accumulation of DEA in a human alveolar epithelium-derived cell line. Biol Pharm Bull 2008;31:1449.
3. Yano T, Itoh Y, Yamada M, Egashira N, Oishi R. Combined treatment with L-carnitine and a pan-caspase inhibitor effectively reverses amiodarone-induced injury in cultured human lung epithelial cells. Apoptosis 2008;13:543.
4. Panchal AM, Seethamraju H, Haque A. Dronedarone induced pulmonary toxicity [abstract]. Am J Respir Crit Care Med 2011;183:A5672.